The susceptibility for MS was analyzed in eight elegible studies that described the frequency and association of the HLA DRB1 alleles, for comparison, among the MS groups ranging from 29 to 300 MS patients24–27,29,31,33. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.